A recent study identifies Neural EGFL-like 2 (NELL2), a secreted protein, as a key regulator of bone homeostasis, offering potential therapeutic applications for osteoporosis.

A major discovery of the study is NELL2’s dual function in bone metabolism: promoting osteoblast differentiation and inhibiting adipocyte formation.